Compare Invesco S&P 500 High Div Low Volatility ETF (SPHD) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco S&P 500 High Div Low Volatility ETF vs 22nd Century Group Inc — how do they compare? Invesco S&P 500 High Div Low Volatility ETF trades at $51.61, while 22nd Century Group Inc trades at $2.17 (market cap $1.50M). The key difference: Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| SPHD | XXII | |
|---|---|---|
52-Week High | $53.55 | $594.00 |
52-Week Low | $46.96 | $2.13 |
Market Cap | — | $1.50M |
Sector | — | Technology |
Enterprise Value | — | -$2.81M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPHD trades at $51.96, down 0.65% on the day, with a technical outlook showing mixed signals—bullish oscillators but bearish moving averages. The ETF offers a high dividend yield, targeting income investors with low volatility exposure. Recent news highlights its role in retirement portfolios but notes potential yield traps without quality filters.
The outlook remains cautious due to valuation concerns and competition from peers like SCHD. Risks include underperformance in total returns and sensitivity to interest rate changes. Income-focused investors may find value, but growth-oriented holders should monitor fundamental weaknesses.
XXII trades at $2.29, down 4.58% today, showing continued bearish momentum with negative technical signals. The company faces severe financial challenges with negative profit margins (-76.01% net income margin) and consecutive earnings misses. Despite analyst optimism (75% buy ratings), fundamental weakness persists with declining revenue and substantial losses. Recent corporate actions include a 20:1 reverse stock split completed June 2026 to maintain listing compliance.
The outlook remains challenging given persistent operational losses and negative cash flow from operations. Investment opportunity exists if the company can capitalize on its claimed $50B market opportunity and improve gross margins. Key risks include continued cash burn, competitive pressures in tobacco alternatives, and execution challenges in commercializing VLN products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
